Genetic and chemical correction of cystic fibrosis reduces airway susceptibility to SARS-CoV-2
Year: 2026
Type: article
Abstract: Using rigorously controlled iPSC-derived airway models, the study shows that CFTR-deficient cells are more vulnerable to SARS-CoV-2 and display stronger inflammation than syngeneic CFTR-corrected controls. The CFTR modulator ETI reduces viral injury and boosts antiviral pathways in both CF and non-CF cells. Even at baseline, CFTR modulation enhances antiviral responses and lowers inflammation. Overall, the findings reveal a broad protective antiviral effect of CFTR modulators and highlight their therapeutic promise in inflammatory lung disease.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1174325391, G234226948, G372985576, G5348336110, G5372302043, G6206609134, G6326271676, Using Induced Pluripotent Stem Cells to Characterize Cystic Fibrosis, Integrated Training in Respiratory Research, Developing Pluripotent Stem Cells to Model and Treat Lung Disease, Derivation of lung epithelia from iPS cells for advanced disease modeling
OpenAlex ID: W7124882301
